SMO Clinplus: Announcement on the early termination of the plan of shareholding reduction by shareholders holding 5% or more of the company's shares.
SMO Clinplus: 2023 Annual Equity Distribution Implementation Notice
SMO Clinplus: Announcement on the change in shareholding ratio of shareholders holding 5% or more of the company's shares to 1%
SMO Clinplus: Announcement on the 2023 Profit Distribution Plan
Pris: Pre-disclosure announcement on shareholders holding 5% or more of the company's shares to reduce their shareholding
Prius: Announcement on the completion of the implementation of the plan to increase the actual controller\'s shareholding
Prius: Announcement on the actual controller\'s plan to increase shareholding
Price: Announcement on the completion of the implementation of the company\'s shareholders\' equity change plan
Prius: Equity Distribution Implementation Notice for the First Three Quarters of 2023
Price: Announcement on the expiration of the period of the company\'s shareholders\' equity change plan
Price: Reminder Notice on the 2022 Restricted Stock Incentive Plan for the First Time Grants Part of the First Release Period to Lift the Sale Restricted Sale Period and Release the Listing and Circulation of Restricted Shares
Price: The Supervisory Board\'s verification opinion on the 2022 Restricted Stock Incentive Plan for the first time, granted some of the first sales period to lift the sales restrictions and the list of incentive targets for the achievement of lifting the
Prius: Announcement on the profit distribution plan for the first three quarters of 2023
Price: Announcement on the achievements of the 2022 Restricted Stock Incentive Plan for the first time granting part of the first lifting period and lifting the conditions for lifting the sale restrictions
Prius: Beijing Guofeng Law Firm\'s Legal Opinion on Prius (Shanghai) Pharmaceutical Technology Development Co., Ltd.\'s 2022 Restricted Stock Incentive Plan Grants for the First Time Part of the First Sale Cancellation Period and the Achievements of Liftin
Prius: Announcement on the early termination of the equity change plan for shareholders holding 5% or more of the company\'s shares and the equity change reaching 1%
Prius: Announcement on the completion of registration of restricted shares reserved for the 2022 Restricted Stock Incentive Plan
Prius: Audit opinion of the Board of Supervisors on the list of incentive recipients reserved for the 2022 restricted stock incentive plan (reserve grant date)
Prius: List of recipients of the 2022 Restricted Stock Incentive Plan Reserve Grant Incentives (Reserve Grant Date)
Prius: Notice on reserving and granting restricted shares to incentive recipients
No Data